Heartflow, Inc. Common Stock (HTFL) vs Mirum Pharmaceuticals, Inc. (MIRM)

A side-by-side comparison of Heartflow, Inc. Common Stock and Mirum Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — HTFL vs MIRM

growth of $100 · dividends reinvested · last 1y
HTFL +81.6% (+81.6%/yr)MIRM +36.1% (+36.1%/yr)HTFL compounded faster over this window
100150200Start $1002026$182$136
HTFL MIRM

HTFL vs MIRM: by the numbers

  • •MIRM is the larger company ($4.83B vs $4.38B market cap).
  • •Both run net losses; HTFL's is the smaller (-55.82% vs -139.18% net margin).

Metrics side by side

Valuation

MetricHTFLMIRM
P/S ratio20.657.81
P/B ratio15.66N/A

Profitability

MetricHTFLMIRM
Gross margin80.08%81.70%
Operating margin-34.31%-4.25%
Net margin-55.82%-139.18%
ROE-42.32%N/A
ROIC-23.69%-13.09%

Growth (annualized)

MetricHTFLMIRM
Revenue CAGR (5Y)N/A123.86%
Total return CAGR (5Y)N/A37.24%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.